Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
OPKO Health Inc. Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.	Israel	OPK
OPKO HEALTH, INC. A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.	United States of America	OPK
Opthea Ltd Biopharma that discontinued its wet AMD therapy after its lead drug failed Phase 3 trials.	United States of America	OPT
OPTUS Pharmaceutical Co., Ltd. Develops and manufactures ophthalmic solutions for dry eye, infections, and inflammation.	South Korea	131030
Opus Genetics, Inc. Developing gene therapies for inherited retinal diseases and other blinding conditions.	United States of America	IRD
ORAGENICS INC Biotech developing intranasal drugs for concussion and other brain disorders.	United States of America	OGEN
Oramed Pharmaceuticals Inc. Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.	Israel	ORMP
ORAMED PHARMACEUTICALS INC. Develops oral drug delivery systems to convert injectable drugs, like insulin, into capsules.	United States of America	ORMP
ORASURE TECHNOLOGIES INC Develops and distributes point-of-care diagnostic tests and sample collection devices.	United States of America	OSUR
Orexo Develops pharmaceuticals & digital health for opioid use disorder in the US market.	Sweden	ORX